148 related articles for article (PubMed ID: 36035221)
1. TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein.
Lu Y; Xiao Y; Yang J; Su H; Zhang X; Su F; Tian B; Zhao D; Ling X; Zhang T
Oxid Med Cell Longev; 2022; 2022():4374978. PubMed ID: 36035221
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A.
Liu C; Sun W; Yang K; Xia B
Exp Cell Res; 2022 Jul; 416(2):113154. PubMed ID: 35421368
[TBL] [Abstract][Full Text] [Related]
3. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6.
Wu YT; Ma SY; Sun WQ; Shen WW; Zhu HT; Zhang Q; Chen HF
J Clin Endocrinol Metab; 2021 Jan; 106(2):526-538. PubMed ID: 33146694
[TBL] [Abstract][Full Text] [Related]
4. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
5. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
6. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
7. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
[TBL] [Abstract][Full Text] [Related]
8. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
[TBL] [Abstract][Full Text] [Related]
9. TRIM65 negatively regulates p53 through ubiquitination.
Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
[TBL] [Abstract][Full Text] [Related]
10. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
[TBL] [Abstract][Full Text] [Related]
11. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
Chen D; Li Y; Zhang X; Wu H; Wang Q; Cai J; Cui Y; Liu H; Lan P; Wang J; Yang Z; Wang L
Oncogene; 2019 Sep; 38(37):6429-6444. PubMed ID: 31332286
[TBL] [Abstract][Full Text] [Related]
13. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
Front Immunol; 2021; 12():741839. PubMed ID: 34512673
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00963 promotes colorectal cancer cell proliferation and metastasis by regulating miR‑1281 and TRIM65.
Lv H; Zhou D; Liu G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498706
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
Oncotarget; 2016 Dec; 7(49):81527-81540. PubMed ID: 27829229
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
17. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
19. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
20. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
